KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Change in Receivables: 2009-2024

Historic Change in Receivables for Biocryst Pharmaceuticals (BCRX) over the last 16 years, with Dec 2024 value amounting to $22.7 million.

  • Biocryst Pharmaceuticals' Change in Receivables fell 120.03% to -$1.3 million in Q4 2015 from the same period last year, while for Dec 2015 it was -$3.2 million, marking a year-over-year decrease of 144.03%. This contributed to the annual value of $22.7 million for FY2024, which is 272.40% up from last year.
  • As of FY2024, Biocryst Pharmaceuticals' Change in Receivables stood at $22.7 million, which was up 272.40% from $6.1 million recorded in FY2023.
  • In the past 5 years, Biocryst Pharmaceuticals' Change in Receivables registered a high of $22.7 million during FY2024, and its lowest value of -$13.9 million during FY2020.
  • Its 3-year average for Change in Receivables is $16.8 million, with a median of $21.5 million in 2022.
  • In the last 5 years, Biocryst Pharmaceuticals' Change in Receivables slumped by 177.87% in 2020 and then surged by 272.40% in 2024.
  • Biocryst Pharmaceuticals' Change in Receivables (Yearly) stood at -$13.9 million in 2020, then skyrocketed by 249.73% to $20.8 million in 2021, then grew by 3.14% to $21.5 million in 2022, then crashed by 71.61% to $6.1 million in 2023, then surged by 272.40% to $22.7 million in 2024.